{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:16:36Z","timestamp":1788243396307,"version":"build-2803163510"},"reference-count":43,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,8,1]]},"DOI":"10.3724\/abbs.2026132","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:33:26Z","timestamp":1784021606000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Nuclear receptor Rev-erb-&amp;alpha; mediates palmitic acid-induced lipid peroxidation in cardiomyocytes"],"prefix":"10.3724","author":[{"given":"Tingting","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengzhou","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","volume":"119","author":"Da Dalt L","year":"2023","unstructured":"Da Dalt L, Cabodevilla AG, Goldberg IJ, Norata GD. Cardiac lipid metabolism, mitochondrial function, and heart failure. Cardiovasc Res, 2023, 119: 1905-1914.","journal-title":"Cardiovasc Res"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1039\/D5FO01237F","volume":"16","author":"Yang R","year":"2025","unstructured":"Yang R, Pang J, Zhong X, Pang S, Hu X, Wei C, Yan W. Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions. Food Funct, 2025, 16: 5961-5993.","journal-title":"Food Funct"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cjca.2025.01.029","volume":"41","author":"Ketema EB","year":"2025","unstructured":"Ketema EB, Lopaschuk GD. The impact of obesity on cardiac energy metabolism and efficiency in heart failure with preserved ejection fraction. Can J Cardiol, 2025, 41: 1699-1714.","journal-title":"Can J Cardiol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/ijms26020788","volume":"26","author":"Ceja-Galicia ZA","year":"2025","unstructured":"Ceja-Galicia ZA, Cespedes-Acu\u00f1a CLA, El-Hafidi M. Protection strategies against palmitic acid-induced lipotoxicity in metabolic syndrome and related diseases. Int J Mol Sci, 2025, 26:","journal-title":"Int J Mol Sci"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"12568","DOI":"10.3389\/jpps.2024.12568","volume":"27","author":"Nakamura M","year":"2024","unstructured":"Nakamura M. Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy. J Pharm Pharm Sci, 2024, 27:","journal-title":"J Pharm Pharm Sci"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/cells14201621","volume":"14","author":"Qiu Y","year":"2025","unstructured":"Qiu Y, Chang S, Zeng Y, Wang X. Advances in mitochondrial dysfunction and its role in cardiovascular diseases. Cells, 2025, 14:","journal-title":"Cells"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3724\/abbs.2025045","volume":"57","author":"Lan C","year":"2025","unstructured":"Lan C, Li Y, Weng Z, Pan W, Lin W, Jiang Z, Yang L. TLR4 mediates lipotoxic \u03b2-cell dysfunction by inhibiting the TMEM24\/PI3K\/AKT pathway. Acta Biochim Biophys Sin, 2025, 57: 1684-1695.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41467-024-45582-8","volume":"15","author":"Wang X","year":"2024","unstructured":"Wang X, Zhu L, Liu J, Ma Y, Qiu C, Liu C, Gong Y. Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling. Nat Commun, 2024, 15:","journal-title":"Nat Commun"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"e99752","DOI":"10.7759\/cureus.99752","volume":"17","author":"Neshat S","year":"2025","unstructured":"Neshat S, Moradi H, Bidares M, Heidari A, Falahati Marvast A, Ortega R, Heshmat K. Sodium-glucose cotransporter 2 (SGLT2) inhibitors and lipid modulation in heart failure: a narrative review. Cureus, 2025, 17:","journal-title":"Cureus"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41573-020-00109-w","volume":"20","author":"Ruan W","year":"2021","unstructured":"Ruan W, Yuan X, Eltzschig HK. Circadian rhythm as a therapeutic target. Nat Rev Drug Discov, 2021, 20: 287-307.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","volume":"21","author":"Patke A","year":"2020","unstructured":"Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms. Nat Rev Mol Cell Biol, 2020, 21: 67-84.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41569-019-0167-4","volume":"16","author":"Crnko S","year":"2019","unstructured":"Crnko S, Du Pr\u00e9 BC, Sluijter JPG, Van Laake LW. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat Rev Cardiol, 2019, 16: 437-447.","journal-title":"Nat Rev Cardiol"},{"key":"CITATION13","doi-asserted-by":"crossref","unstructured":"Pan X, Mota S, Zhang B. Circadian clock regulation on lipid metabolism and metabolic diseases.  Adv Exp Med Biol  2020, 1276: 53\u201366 .","DOI":"10.1007\/978-981-15-6082-8_5"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"e70435","DOI":"10.1002\/mco2.70435","volume":"6","author":"Zha K","year":"2025","unstructured":"Zha K, Mi B, Xiong Y, Wu S, Lu L, Zhang S, Lu X. Circadian rhythm: biological functions, diseases, and therapeutic targets. MedComm, 2025, 6:","journal-title":"MedComm"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1042\/CS20256383","volume":"139","author":"Froy O","year":"2025","unstructured":"Froy O, Weintraub Y. The circadian clock, metabolism, and inflammation\u2014the holy trinity of inflammatory bowel diseases. Clin Sci, 2025, 139: 777-790.","journal-title":"Clin Sci"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.tem.2024.11.010","volume":"36","author":"Young MJ","year":"2025","unstructured":"Young MJ, Heanue S, Kanki M, Moneghetti KJ. Circadian disruption and its impact on the cardiovascular system. Trends Endocrinol Metab, 2025, 36: 842-854.","journal-title":"Trends Endocrinol Metab"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"e2417678121","DOI":"10.1073\/pnas.2417678121","volume":"121","author":"Woodie LN","year":"2024","unstructured":"Woodie LN, Alberto AJ, Krusen BM, Melink LC, Lazar MA. Genetic synchronization of the brain and liver molecular clocks defend against chrono-metabolic disease. Proc Natl Acad Sci USA, 2024, 121:","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s44161-021-00001-9","volume":"1","author":"Dierickx P","year":"2022","unstructured":"Dierickx P, Zhu K, Carpenter BJ, Jiang C, Vermunt MW, Xiao Y, Luongo TS. Circadian REV-ERBs repress E4bp4 to activate NAMPT-dependent NAD+ biosynthesis and sustain cardiac function. Nat Cardiovasc Res, 2022, 1: 45-58.","journal-title":"Nat Cardiovasc Res"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41401-022-00883-w","volume":"43","author":"Griffett K","year":"2022","unstructured":"Griffett K, Hayes ME, Boeckman MP, Burris TP. The role of REV-ERB in NASH. Acta Pharmacol Sin, 2022, 43: 1133-1140.","journal-title":"Acta Pharmacol Sin"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.jacc.2022.03.370","volume":"79","author":"Zhao Y","year":"2022","unstructured":"Zhao Y, Lu X, Wan F, Gao L, Lin N, He J, Wei L. Disruption of circadian rhythms by shift work exacerbates reperfusion injury in myocardial infarction. J Am Coll Cardiol, 2022, 79: 2097-2115.","journal-title":"J Am Coll Cardiol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.121.056076","volume":"145","author":"Song S","year":"2022","unstructured":"Song S, Tien CL, Cui H, Basil P, Zhu N, Gong Y, Li W. Myocardial Rev-erb-mediated diurnal metabolic rhythm and obesity paradox. Circulation, 2022, 145: 448-464.","journal-title":"Circulation"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"e63324","DOI":"10.7554\/eLife.63324","volume":"10","author":"Hunter AL","year":"2021","unstructured":"Hunter AL, Pelekanou CE, Barron NJ, Northeast RC, Grudzien M, Adamson AD, Downton P. Adipocyte NR1D1 dictates adipose tissue expansion during obesity. eLife, 2021, 10:","journal-title":"eLife"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"12954","DOI":"10.3390\/ijms232112954","volume":"23","author":"Raza GS","year":"2022","unstructured":"Raza GS, Sodum N, Kaya Y, Herzig KH. Role of circadian transcription factor Rev-erb in metabolism and tissue fibrosis. Int J Mol Sci, 2022, 23:","journal-title":"Int J Mol Sci"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"113595","DOI":"10.1016\/j.biopha.2022.113595","volume":"154","author":"Huang Q","year":"2022","unstructured":"Huang Q, Tian L, Zhao X, Lei S, Zhao B, Qiu Z, Xia ZY. Rev-erbs agonist SR9009 alleviates ischemia-reperfusion injury by heightening endogenous cardioprotection at onset of type-2 diabetes in rats: down-regulating ferritinophagy\/ferroptosis signaling. Biomed Pharmacother, 2022, 154:","journal-title":"Biomed Pharmacother"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41419-022-05392-6","volume":"13","author":"Xu H","year":"2022","unstructured":"Xu H, Zhang J, Zheng X, Tan P, Xiong X, Yi X, Yang Y. SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXR\u03b1\/FOXM1 pathway independently of REV-ERBs. Cell Death Dis, 2022, 13:","journal-title":"Cell Death Dis"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"952114","DOI":"10.3389\/fcvm.2022.952114","volume":"9","author":"Li H","year":"2022","unstructured":"Li H, Song S, Tien CL, Qi L, Graves A, Nasiotis E, Burris TP. SR9009 improves heart function after pressure overload independent of cardiac REV-ERB. Front Cardiovasc Med, 2022, 9:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"848364","DOI":"10.3389\/fgene.2022.848364","volume":"13","author":"Xi Y","year":"2022","unstructured":"Xi Y, Chen D, Dong Z, Lam H, He J, Du K, Chen C. RNA sequencing of cardiac in a rat model uncovers potential target lncRNA of diabetic cardiomyopathy. Front Genet, 2022, 13:","journal-title":"Front Genet"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cels.2018.10.007","volume":"7","author":"Torre D","year":"2018","unstructured":"Torre D, Lachmann A, Ma\u2032ayan A. BioJupies: automated generation of interactive notebooks for RNA-Seq data analysis in the cloud. Cell Syst, 2018, 7: 556-561.e3.","journal-title":"Cell Syst"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"Shen W","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, Qian X. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta, 2022, 1:","journal-title":"iMeta"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3724\/abbs.2022104","volume":"54","author":"Chen Z","year":"2022","unstructured":"Chen Z, Zhuang Z, Meng C, Zhu Z, Zhang Y, Zhang Z. Induction of the ER stress response in NRVMs is linked to cardiotoxicity caused by celastrol. Acta Biochim Biophys Sin, 2022, 54: 1180-1192.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"116951","DOI":"10.1016\/j.taap.2024.116951","volume":"486","author":"Zhang MR","year":"2024","unstructured":"Zhang MR, Zuo BY, Song YC, Guo DD, Li QL, Lyu JX, Zhu H. BDNF mimetics recover palmitic acid-induced injury in cardiomyocytes by ameliorating Akt-dependent mitochondrial impairments. Toxicol Appl Pharmacol, 2024, 486:","journal-title":"Toxicol Appl Pharmacol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2023.02.006","volume":"198","author":"Hang PZ","year":"2023","unstructured":"Hang PZ, Ge FQ, Zhang MR, Li QH, Yu HQ, Song YC, Guo DD. BDNF mimetic 7,8-dihydroxyflavone rescues rotenone-induced cytotoxicity in cardiomyocytes by ameliorating mitochondrial dysfunction. Free Radical Biol Med, 2023, 198: 83-91.","journal-title":"Free Radical Biol Med"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3724\/abbs.2024232","volume":"57","author":"Yang H","year":"2025","unstructured":"Yang H, Xiao G, Wang D, Xiong T, Wang J, Jing X, Xiong B. Inhibition of HMOX1 alleviates diabetic cardiomyopathy by targeting ferroptosis. Acta Biochim Biophys Sin, 2025, 57: 1420-1432.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/sj.bjp.0707372","volume":"152","author":"Lew M","year":"2007","unstructured":"Lew M. Good statistical practice in pharmacology. Problem 2. Br J Pharmacol, 2007, 152: 299-303.","journal-title":"Br J Pharmacol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"111006","DOI":"10.1016\/j.cellsig.2023.111006","volume":"114","author":"Tian H","year":"2024","unstructured":"Tian H, Huang Q, Cheng J, Xiong Y, Xia Z. Rev-erb\u03b1 attenuates diabetic myocardial injury through regulation of ferroptosis. Cell Signal, 2024, 114:","journal-title":"Cell Signal"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biochi.2004.12.006","volume":"87","author":"Laitinen S","year":"2005","unstructured":"Laitinen S, Fontaine C, Fruchart JC, Staels B. The role of the orphan nuclear receptor Rev-Erb\u03b1 in adipocyte differentiation and function. Biochimie, 2005, 87: 21-25.","journal-title":"Biochimie"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"Cho H","year":"2012","unstructured":"Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW. Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature, 2012, 485: 123-127.","journal-title":"Nature"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1073\/pnas.1000438107","volume":"107","author":"Yin L","year":"2010","unstructured":"Yin L, Joshi S, Wu N, Tong X, Lazar MA. E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb\u03b1. Proc Natl Acad Sci USA, 2010, 107: 11614-11619.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"177162","DOI":"10.1016\/j.ejphar.2024.177162","volume":"987","author":"Takaguri A","year":"2025","unstructured":"Takaguri A, Shinohe S, Noro R, Sakuraba M, Satoh C, Ohashi R, Satoh K. SR9009 attenuates TGF-\u03b21-induced renal fibrotic responses by inhibiting the NOX4\/p38 signaling pathway in NRK-49F cells. Eur J Pharmacol, 2025, 987:","journal-title":"Eur J Pharmacol"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"12147","DOI":"10.1073\/pnas.1904226116","volume":"116","author":"Dierickx P","year":"2019","unstructured":"Dierickx P, Emmett MJ, Jiang C, Uehara K, Liu M, Adlanmerini M, Lazar MA. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. Proc Natl Acad Sci USA, 2019, 116: 12147-12152.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"899628","DOI":"10.3389\/fphar.2022.899628","volume":"13","author":"Luo X","year":"2022","unstructured":"Luo X, Song S, Qi L, Tien CL, Li H, Xu W, Mathuram TL. REV-ERB is essential in cardiac fibroblasts homeostasis. Front Pharmacol, 2022, 13:","journal-title":"Front Pharmacol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.3390\/ijms20246320","volume":"20","author":"Ishimaru K","year":"2019","unstructured":"Ishimaru K, Nakajima S, Yu G, Nakamura Y, Nakao A. The putatively specific synthetic REV-ERB agonist Sr9009 inhibits IgE- and IL-33-mediated mast cell activation independently of the circadian clock. Int J Mol Sci, 2019, 20:","journal-title":"Int J Mol Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"102261","DOI":"10.1016\/j.redox.2022.102261","volume":"51","author":"Huang S","year":"2022","unstructured":"Huang S, Liu CH, Wang Z, Fu Z, Britton WR, Blomfield AK, Kamenecka TM. REV-ERB\u03b1 regulates age-related and oxidative stress-induced degeneration in retinal pigment epithelium via NRF2. Redox Biol, 2022, 51:","journal-title":"Redox Biol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/11ABB63DE99840D38AF3F921AC4E7EF7","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/11ABB63DE99840D38AF3F921AC4E7EF7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:03:53Z","timestamp":1788242633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026132","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}